Found 4 bookmarks
Custom sorting
Metabolic Syndrome and COVID-19 | Bentham Science Publishers
Metabolic Syndrome and COVID-19 | Bentham Science Publishers
“The threat of different COVID-19 variants emerging that could cause new increases in morbidity and mortality remains.”
The threat of different COVID-19 variants emerging that could cause new increases in morbidity and mortality remains.
·benthamdirect.com·
Metabolic Syndrome and COVID-19 | Bentham Science Publishers
New Onset Diabetes After COVID 19 (NODAC) is predominantly due to exacerbated Insulin Resistance (IR) rather than beta cell dysfunction: Lessons from tertiary care hospital data during confluence of two epidemics
New Onset Diabetes After COVID 19 (NODAC) is predominantly due to exacerbated Insulin Resistance (IR) rather than beta cell dysfunction: Lessons from tertiary care hospital data during confluence of two epidemics

New onset diabetes after COVID-19 (NODAC)

"Patients with NODAC have evidence of persistent insulin resistance on follow up, underscoring the need for long term glycemic monitoring."

·link.springer.com·
New Onset Diabetes After COVID 19 (NODAC) is predominantly due to exacerbated Insulin Resistance (IR) rather than beta cell dysfunction: Lessons from tertiary care hospital data during confluence of two epidemics